Crohns & Colitis Foundation Perspectives

Host: Jenn Simmons, MD Guest: Jill K. Gaidos, MD The evolution of therapies for inflammatory bowel disease (IBD) has been nothing short of remarkable, which means it’s time that we take stock of the latest treatment targets, disease mechanism updates, drug pipeline developments, and patient safety considerations. And here to help us do just that is Dr. Jill Gaidos, Associate Professor of Medicine in the Division of Gastroenterology, Hepatology, and Nutrition at Virginia Commonwealth University.